Koligo introduces KYSLECEL™ autologous cell therapy product

LOUISVILLE, Ky., Aug. 22, 2018 /PRNewswire/ -- Koligo Therapeutics, Inc. today announced the formal introduction of KYSLECEL in the Eastern United States. What is KYSLECEL? KYSLECEL is made from a patient's own pancreatic islets – the cells that make insulin to regulate blood sugar....